Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yamada Fowler, Naomi ^a   Fredrikson, Mats ^a   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COFFEE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GRIN2A GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAFFEINE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE; RISK FACTORS; SWEDEN;

EID: 84902668525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099294     Document Type: Article

References (21)

1. Mata IF, Yearout D, Alvarez V, Coto E, de Mena L, et al. (2011) Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease. Mov Disord 26: 819-823.
2. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74: 97-109.
3. Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, et al. (2011) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 7: e1002237. Available: http://www.plosgenetics.org/article/info%3Adoi%2F10. 1371%2Fjournal.pgen.1002237 Accessed 2014 January 15.
4. Larsson SC, Giovannucci E, Wolk A (2006) Coffee consumption and stomach cancer risk in a cohort of Swedish women. Int J Cancer 119: 2186-9. (Pubitemid 44423679)
5. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, et al. (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43: 513-518.
6. Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, et al. (2011) NMDA receptor gene variations as modifiers in Huntington disease: a replication study. PLoS Curr 3: RRN1247. Available: http://currents.plos.org/hd/article/ nmda-receptor-gene-variations-as-modifiers-in-huntington-disease-a-replication- study/. Accessed 2014 January 15.
7. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, et al. (2010) Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42: 1021-1026.
8. Turic D, Langley K, Mills S, Stephens M, Lawson D, et al. (2004) Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 9: 169-173. (Pubitemid 38299530)
9. Iwayama-Shigeno Y, Yamada K, Itokawa M, Toyota T, Meerabux JM, et al. (2005) Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia. Neurosci Lett 378: 102-105. (Pubitemid 40354295)
10. Itokawa M, Yamada K, Iwayama-Shigeno Y, Ishitsuka Y, Detera-Wadleigh S,et al. (2003) Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans. Neurosci Lett 345: 53-56. (Pubitemid 36694848)
11. Higley MJ, Sabatini BL (2010) Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci 13: 958-966.
12. Boeck CR, Kroth EH, Bronzatto MJ, Vendite D (2005) Adenosine receptors cooperate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity. Neuropharmacology 49: 17-24. (Pubitemid 40910012)
13. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 26 Suppl 1:S1-58.
14. Hallström H, Wolk A, Glynn A, Michaëlsson K (2006) Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 17: 1055-1064.
15. Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, et al. (2012) Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79: 659-667.
16. Winkler S, König IR, Lohmann-Hedrich K, Vieregge P, Kostic V, et al. (2007) Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Eur J Hum Genet 15: 1163-1168. (Pubitemid 350011681)
17. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303-1307.
18. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-590.
19. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42: 781-785.
20. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16: 85-91.
21. Gelber RP, Petrovitch H, Masaki KH, Ross GW, White LR (2011) Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis 23: 607-615.